Astrazeneca Imfinzi perioperative regimen gains positive EU CHMP opinion in early gastric cancer

I Peace generates human iPS cells from NKT cells and offers them for research use

Trace Biosciences' IND application for nerve-specific imaging agent approved by FDA

Frontage expands early phase clinical research capabilities across US and China

AstraZeneca agrees obesity and type 2 diabetes collaboration with CSPC

Ascletis Pharma Inc reports topline results from Phase III open-label study of denifanstat

Innovative Molecules GmbH completes Phase 1 clinical development programme for adibelivir

MicuRx Pharmaceuticals' IND application for MRX-5 cleared by FDA

FDA approves Tenpoint Therapeutics' YUVEZZI as first dual-agent eye drop for presbyopia

Summit Therapeutics' BLA for ivonescimab in EGFR-mutated NSCLC accepted by FDA

OSE Immunotherapeutics prioritises pouchitis and hidradenitis suppurativa for lusvertikimab development

WuXi Biologics collaborates with Sinorda Biomedicine for antibody development

Solvonis expands SVN-015 into depression following positive preclinical data

Biogen's litifilimab receives FDA Breakthrough Therapy Designation for CLE

Glaukos receives FDA approval for repeat administration of iDose TR